Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02569476
Title BGB 3111 in Combination With Obinutuzumab in Subjects With B-Cell Lymphoid Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors BeiGene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Florida Cancer Specialists Fort Myers Fort Myers Florida 33916 United States Details
Florida Cancer Specialists East West Palm Beach Florida 33401 United States Details
Tennessee Oncology Nashville Tennessee 37205 United States Details
St George Hospital Kogarah New South Wales 2217 Australia Details
Brisbane Clinic For Lymphoma Greenslopes Queensland 4120 Australia Details
Ashford Cancer Centre Research Northeast Windsor Gardens South Australia 5087 Australia Details
St Vincents Hospital Melbourne Fitzroy Victoria 3065 Australia Details
Barwon Health the Geelong Hospital Geelong Victoria 3220 Australia Details
St Frances Xavier Cabrini Hospital Malvern Victoria 3144 Australia Details
The Alfred Hospital Melbourne Victoria 3004 Australia Details
Royal Perth Hospital Perth Western Australia 6000 Australia Details
Asan Medical Center Seoul Seoul Teugbyeolsi 05505 Korea, Republic of Details
Gangnam Severance Hospital, Yonsei University Health System Seoul Seoul Teugbyeolsi 06273 Korea, Republic of Details
Samsung Medical Center Seoul Seoul Teugbyeolsi 06351 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field